Insight Molecular Diagnostics Stock Technical Analysis
| IMDX Stock | 5.57 0.01 0.18% |
As of the 15th of February 2026, Insight Molecular retains the Risk Adjusted Performance of (0.01), standard deviation of 5.59, and Market Risk Adjusted Performance of (0.05). Insight Molecular technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Insight Molecular Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Insight, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to InsightInsight Molecular's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insight Molecular. Market participants price Insight higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Insight Molecular assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (3.79) | Revenue Per Share | Quarterly Revenue Growth 11.148 | Return On Assets | Return On Equity |
Understanding Insight Molecular requires distinguishing between market price and book value, where the latter reflects Insight's accounting equity. The concept of intrinsic value - what Insight Molecular's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Insight Molecular's price substantially above or below its fundamental value.
Please note, there is a significant difference between Insight Molecular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insight Molecular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Insight Molecular's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Insight Molecular 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Insight Molecular's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Insight Molecular.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Insight Molecular on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Insight Molecular Diagnostics or generate 0.0% return on investment in Insight Molecular over 90 days. Insight Molecular is related to or competes with Allurion Technologies, Aethlon Medical, Co Diagnostics, Vivos Therapeutics, Ekso Bionics, Adagio Medical, and Aytu BioScience. Insight Molecular is entity of United States More
Insight Molecular Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Insight Molecular's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Insight Molecular Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 35.29 | |||
| Value At Risk | (7.38) | |||
| Potential Upside | 9.42 |
Insight Molecular Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Insight Molecular's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Insight Molecular's standard deviation. In reality, there are many statistical measures that can use Insight Molecular historical prices to predict the future Insight Molecular's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | (0.06) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Insight Molecular's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Insight Molecular February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.05) | |||
| Mean Deviation | 4.14 | |||
| Coefficient Of Variation | (3,916) | |||
| Standard Deviation | 5.59 | |||
| Variance | 31.26 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | (0.06) | |||
| Maximum Drawdown | 35.29 | |||
| Value At Risk | (7.38) | |||
| Potential Upside | 9.42 | |||
| Skewness | (0.63) | |||
| Kurtosis | 3.04 |
Insight Molecular Backtested Returns
Insight Molecular holds Efficiency (Sharpe) Ratio of -0.0322, which attests that the entity had a -0.0322 % return per unit of risk over the last 3 months. Insight Molecular exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Insight Molecular's Standard Deviation of 5.59, risk adjusted performance of (0.01), and Market Risk Adjusted Performance of (0.05) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 2.58, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Insight Molecular will likely underperform. At this point, Insight Molecular has a negative expected return of -0.16%. Please make sure to check out Insight Molecular's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Insight Molecular performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.23 |
Weak reverse predictability
Insight Molecular Diagnostics has weak reverse predictability. Overlapping area represents the amount of predictability between Insight Molecular time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Insight Molecular price movement. The serial correlation of -0.23 indicates that over 23.0% of current Insight Molecular price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.23 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.32 |
Insight Molecular technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Insight Molecular Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Insight Molecular across different markets.
About Insight Molecular Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Insight Molecular Diagnostics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Insight Molecular Diagnostics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Insight Molecular price pattern first instead of the macroeconomic environment surrounding Insight Molecular. By analyzing Insight Molecular's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Insight Molecular's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Insight Molecular specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.001654 | 0.00147 | Price To Sales Ratio | 19.02 | 18.07 |
Insight Molecular February 15, 2026 Technical Indicators
Most technical analysis of Insight help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Insight from various momentum indicators to cycle indicators. When you analyze Insight charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.05) | |||
| Mean Deviation | 4.14 | |||
| Coefficient Of Variation | (3,916) | |||
| Standard Deviation | 5.59 | |||
| Variance | 31.26 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | (0.06) | |||
| Maximum Drawdown | 35.29 | |||
| Value At Risk | (7.38) | |||
| Potential Upside | 9.42 | |||
| Skewness | (0.63) | |||
| Kurtosis | 3.04 |
Insight Molecular February 15, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Insight stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.12 | ||
| Daily Balance Of Power | (0.01) | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 5.69 | ||
| Day Typical Price | 5.65 | ||
| Price Action Indicator | (0.12) | ||
| Market Facilitation Index | 0.72 |
Additional Tools for Insight Stock Analysis
When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.